General information about company

Scrip code*500412
NSE Symbol*TIRUMALCHM
MSEI Symbol*NOTLISTED
ISIN*INE338A01024
Name of companyThirumalai Chemicals Limited
Type of companyMain Board
Class of securityEquity
Date of start of financial year01-04-2025
Date of end of financial year31-03-2026
Date of board meeting when results were approved08-11-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange04-11-2025
Description of presentation currencyINR
Level of roundingLakhs
Reporting TypeQuarterly
Reporting QuarterSecond quarter
Nature of report standalone or consolidatedConsolidated
Whether results are audited or unaudited for the quarter endedUnaudited
Whether results are audited or unaudited for the Year to date for current period ended/year endedUnaudited
Segment ReportingSingle segment
Description of single segmentChemical products and its intermediaries
Start date and time of board meeting08-11-2025 10:30
End date and time of board meeting08-11-2025 14:20
Whether cash flow statement is applicable on companyYes
Type of cash flow statementCash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualificationNot applicable



Financial Results – Ind-AS

Particulars3 months/ 6 months ended (dd-mm-yyyy)Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period01-07-202501-04-2025
Date of end of reporting period30-09-202530-09-2025
Whether results are audited or unauditedUnauditedUnaudited
Nature of report standalone or consolidatedConsolidatedConsolidated
Part IBlue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1Income
Revenue from operations4453789542
Other income839666
Total income4537690208
2Expenses
(a)Cost of materials consumed3839274914
(b)Purchases of stock-in-trade5687
(c)Changes in inventories of finished goods, work-in-progress and stock-in-trade-4413-4315
(d)Employee benefit expense 23974719
(e)Finance costs25724391
(f)Depreciation, depletion and amortisation expense22794443
(g)Other Expenses
1Other Expenses847016783
Total other expenses847016783
Total expenses49753101022
3Total profit before exceptional items and tax-4377-10814
4Exceptional items 00
5Total profit before tax-4377-10814
6Tax expense
7Current tax00
8Deferred tax-1039-1480
9Total tax expenses-1039-1480
10Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement00
11Net Profit Loss for the period from continuing operations-3338-9334
12Profit (loss) from discontinued operations before tax00
13Tax expense of discontinued operations00
14Net profit (loss) from discontinued operation after tax00
15Share of profit (loss) of associates and joint ventures accounted for using equity method00
16Total profit (loss) for period-3338-9334
17Other comprehensive income net of taxes21263070
18Total Comprehensive Income for the period-1212-6264
19Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21Details of equity share capital
Paid-up equity share capital11871187
Face value of equity share capital11
22Reserves excluding revaluation reserve
23Earnings per share
iEarnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations-3.07-8.84
Diluted earnings (loss) per share from continuing operations-3.07-8.84
iiEarnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations00
Diluted earnings (loss) per share from discontinued operations00
iiiEarnings per equity share (for continuing and discontinued operations)
Basic earnings (loss) per share from continuing and discontinued operations-3.07-8.84
Diluted earnings (loss) per share from continuing and discontinued operations-3.07-8.84
24Debt equity ratioTextual Information( 1)
25Debt service coverage ratioTextual Information( 2)
26Interest service coverage ratioTextual Information( 3)
27Disclosure of notes on financial resultsTextual Information(4)

Text Block

Textual Information(4)1. The Audit Committee has reviewed and the Board of Directors have approved the above results at their respective meetings held on 07 November 2025 and 08 November 2025 respectively. The Statutory Auditors of the Company have carried out Limited Review of the aforesaid results.
2. In accordance with Ind AS 108, Operating Segments, the Group has identified manufacture and sale of organic chemicals as the only reportable segment.
3. The Standalone and Consolidated financial results have been prepared in accordance with recognition and measurement principles laid down in the Indian Accounting Standard 34, Interim financial reporting (Ind AS 34), prescribed under Section 133 of the Companies Act 2013, and other accounting principles generally accepted in India and is in compliance with the presentation and disclosure requirements of the Regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 as amended.
4. On 26 August 2025, the Company has allotted 1,62,68,040 equity shares of Rs.1/- each pursuant to a Preferential Issue as per the relevant provisions of SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 at a price of Rs. 277/- per share aggregating to Rs. 45,062 lakhs.



Statement of Asset and Liabilities

ParticularsHalf Year ended (dd-mm-yyyy)
Date of start of reporting period01-04-2025
Date of end of reporting period30-09-2025
Whether results are audited or unauditedUnaudited
Nature of report standalone or consolidatedConsolidated
Assets
1 Non-current assets
Property, plant and equipment128074
Capital work-in-progress173983
Investment property
Goodwill0
Other intangible assets9
Intangible assets under development
Biological assets other than bearer plants
Investments accounted for using equity method
Non-current financial assets
Non-current investments19735
Trade receivables, non-current
Loans, non-current0
Other non-current financial assets543
Total non-current financial assets20278
Deferred tax assets (net)
Other non-current assets2735
Total non-current assets325079
2Current assets
Inventories35920
Current financial asset
Current investments1282
Trade receivables, current20478
Cash and cash equivalents19570
Bank balance other than cash and cash equivalents16133
Loans, current0
Other current financial assets762
Total current financial assets58225
Current tax assets (net)1099
Other current assets14131
Total current assets109375
3Non-current assets classified as held for sale
4Regulatory deferral account debit balances and related deferred tax Assets
Total assets434454
Total current assets109375
3Non-current assets classified as held for sale
4Regulatory deferral account debit balances and related deferred tax Assets
Total assets434454
Equity and liabilities
1Equity
Equity attributable to owners of parent
Equity share capital1187
Other equity152053
Total equity attributable to owners of parent153240
Non controlling interest
Total equity153240
2Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current155571
Trade Payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises
Total Trade payable
Other non-current financial liabilities21222
Total non-current financial liabilities176793
Provisions, non-current1518
Deferred tax liabilities (net)4838
Deferred government grants, Non-current
Other non-current liabilities4262
Total non-current liabilities187411
Current liabilities
Current financial liabilities
Borrowings, current44836
Trade Payables, current
(A) Total outstanding dues of micro enterprises and small enterprises715
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises36988
Total Trade payable37703
Other current financial liabilities10034
Total current financial liabilities92573
Other current liabilities677
Provisions, current553
Current tax liabilities (Net)
Deferred government grants, Current
Total current liabilities93803
3Liabilities directly associated with assets in disposal group classified as held for sale
4Regulatory deferral account credit balances and related deferred tax liability
Total liabilities281214
Total equity and liabilities434454
Disclosure of notes on assets and liabilitiesTextual Information(1)

Other Comprehensive Income

Date of start of reporting period01-07-202501-04-2025
Date of end of reporting period30-09-202530-09-2025
Whether results are audited or unauditedUnauditedUnaudited
Nature of report standalone or consolidatedConsolidatedConsolidated
Other comprehensive income [Abstract]
1Amount of items that will not be reclassified to profit and loss
1Re-measurements of defined benefit plans-76.00-74.00
2Equity instruments through other comprehensive income, net-1591.00-225.00
Total Amount of items that will not be reclassified to profit and loss-1667.00-299.00
2Income tax relating to items that will not be reclassified to profit or loss -252.00-50.00
3Amount of items that will be reclassified to profit and loss
1Exchange differences on translation of foreign operations3630.003605.00
2Cash flow hedge reserve-89.00-286.00
Total Amount of items that will be reclassified to profit and loss3541.003319.00
4Income tax relating to items that will be reclassified to profit or loss 0.000.00
5Total Other comprehensive income2126.003070.00


Cash flow statement, indirect

ParticularsHalf Year ended (dd-mm-yyyy)
Date of start of reporting period01-04-2025
Date of end of reporting period30-09-2025
Whether results are audited or unauditedUnaudited
Nature of report standalone or consolidatedConsolidated
Part IBlue color marked fields are non-mandatory.
1Statement of cash flows
Cash flows from used in operating activities
Profit before tax-10814
2Adjustments for reconcile profit (loss)
Adjustments for finance costs4391
Adjustments for decrease (increase) in inventories-11141
Adjustments for decrease (increase) in trade receivables, current-383
Adjustments for decrease (increase) in trade receivables, non-current0
Adjustments for decrease (increase) in other current assets-768
Adjustments for decrease (increase) in other non-current assets898
Adjustments for other financial assets, non-current256
Adjustments for other financial assets, current-901
Adjustments for other bank balances0
Adjustments for increase (decrease) in trade payables, current-4583
Adjustments for increase (decrease) in trade payables, non-current0
Adjustments for increase (decrease) in other current liabilities-134
Adjustments for increase (decrease) in other non-current liabilities0
Adjustments for depreciation and amortisation expense4443
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss0
Adjustments for provisions, current0
Adjustments for provisions, non-current0
Adjustments for other financial liabilities, current-6488
Adjustments for other financial liabilities, non-current0
Adjustments for unrealised foreign exchange losses gains0
Adjustments for dividend income227
Adjustments for interest income101
Adjustments for share-based payments0
Adjustments for fair value losses (gains)0
Adjustments for undistributed profits of associates0
Other adjustments for which cash effects are investing or financing cash flow0
Other adjustments to reconcile profit (loss)0
Other adjustments for non-cash items-1127
Share of profit and loss from partnership firm or association of persons or limited liability partnerships0
Total adjustments for reconcile profit (loss)-15865
Net cash flows from (used in) operations-26679
Dividends received0
Interest paid0
Interest received0
Income taxes paid (refund)166
Other inflows (outflows) of cash0
Net cash flows from (used in) operating activities-26845
3Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses0
Cash flows used in obtaining control of subsidiaries or other businesses0
Other cash receipts from sales of equity or debt instruments of other entities0
Other cash payments to acquire equity or debt instruments of other entities1282
Other cash receipts from sales of interests in joint ventures0
Other cash payments to acquire interests in joint ventures0
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships0
Cash payment for investment in partnership firm or association of persons or limited liability partnerships0
Proceeds from sales of property, plant and equipment0
Purchase of property, plant and equipment0
Proceeds from sales of investment property0
Purchase of investment property0
Proceeds from sales of intangible assets0
Purchase of intangible assets0
Proceeds from sales of intangible assets under development0
Purchase of intangible assets under development0
Proceeds from sales of goodwill0
Purchase of goodwill0
Proceeds from biological assets other than bearer plants0
Purchase of biological assets other than bearer plants0
Proceeds from government grants0
Proceeds from sales of other long-term assets0
Purchase of other long-term assets0
Cash advances and loans made to other parties0
Cash receipts from repayment of advances and loans made to other parties0
Cash payments for future contracts, forward contracts, option contracts and swap contracts0
Cash receipts from future contracts, forward contracts, option contracts and swap contracts0
Dividends received249
Interest received134
Income taxes paid (refund)0
Other inflows (outflows) of cash-34071
Net cash flows from (used in) investing activities-34970
4Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries0
Payments from changes in ownership interests in subsidiaries0
Proceeds from issuing shares45062
Proceeds from issuing other equity instruments0
Payments to acquire or redeem entity's shares0
Payments of other equity instruments0
Proceeds from exercise of stock options0
Proceeds from issuing debentures notes bonds etc0
Proceeds from borrowings97616
Repayments of borrowings60458
Payments of lease liabilities611
Dividends paid0
Interest paid19829
Income taxes paid (refund)0
Other inflows (outflows) of cash0
Net cash flows from (used in) financing activities61780
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes-35
5Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents1314
Net increase (decrease) in cash and cash equivalents1279
Cash and cash equivalents cash flow statement at beginning of period18291
Cash and cash equivalents cash flow statement at end of period19570